Thrombosis in Myeloproliferative Neoplasms: A Single Center Experience of Using Whole Blood Platelet Aggregation Studies for Risk Assessment and Thromboprophylaxis.

Arumugam ManoharanRosalie GemmellLauren CavanaughNoor Shadood

Published in: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis (2022)

Routine use of WBPA studies enables safe and effective risk-adapted thromboprophylaxis in MPN patients, irrespective of the underlying driver mutation and their risk predicted by the IPSET- thrombosis criteria.

Keyphrases

risk assessment
pulmonary embolism
end stage renal disease
venous thromboembolism
newly diagnosed
ejection fraction
prognostic factors
direct oral anticoagulants
case control
peritoneal dialysis
heavy metals
clinical practice
patient reported outcomes
patient reported